Sectra AB (publ) (SECT-B.ST)
SEK 275.2
(-0.22%)
SEK 275.2
(-0.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 36.59 Million SEK | -0.03% |
| 2022 | 36.6 Million SEK | 54.56% |
| 2021 | 23.68 Million SEK | -4.62% |
| 2020 | 24.82 Million SEK | -23.75% |
| 2019 | 32.56 Million SEK | -20.31% |
| 2018 | 40.85 Million SEK | 36.11% |
| 2017 | 30.01 Million SEK | 21.5% |
| 2016 | 24.7 Million SEK | 81.72% |
| 2015 | 13.59 Million SEK | -6.94% |
| 2014 | 14.61 Million SEK | 25.05% |
| 2013 | 11.68 Million SEK | -0.02% |
| 2012 | 11.68 Million SEK | -20.66% |
| 2011 | 14.72 Million SEK | -74.25% |
| 2010 | 57.18 Million SEK | -0.52% |
| 2009 | 57.48 Million SEK | -32.21% |
| 2008 | 84.79 Million SEK | 41.19% |
| 2007 | 60.05 Million SEK | 26.3% |
| 2006 | 47.55 Million SEK | 6.26% |
| 2005 | 44.75 Million SEK | 30.61% |
| 2004 | 34.26 Million SEK | 244.34% |
| 2003 | 9.95 Million SEK | -15.1% |
| 2002 | 11.71 Million SEK | -28.51% |
| 2001 | 16.39 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - SEK | -100.0% |
| 2023 Q1 | 1.00 SEK | -100.0% |
| 2023 Q4 | 36.59 Million SEK | 3658999900.0% |
| 2023 Q3 | 1.00 SEK | -100.0% |
| 2023 Q2 | 918.17 Million SEK | 91817699900.0% |
| 2023 FY | 36.59 Million SEK | -0.03% |
| 2022 Q3 | 1.00 SEK | -100.0% |
| 2022 FY | 36.6 Million SEK | 54.56% |
| 2022 Q2 | 584.65 Million SEK | 0.0% |
| 2022 Q1 | - SEK | -100.0% |
| 2022 Q4 | 36.6 Million SEK | 3660099900.0% |
| 2021 Q1 | - SEK | -100.0% |
| 2021 Q2 | - SEK | 0.0% |
| 2021 Q3 | - SEK | 0.0% |
| 2021 Q4 | 23.68 Million SEK | 0.0% |
| 2021 FY | 23.68 Million SEK | -4.62% |
| 2020 FY | 24.82 Million SEK | -23.75% |
| 2020 Q1 | - SEK | -100.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2020 Q4 | 24.82 Million SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q1 | - SEK | -100.0% |
| 2019 FY | 32.56 Million SEK | -20.31% |
| 2019 Q4 | 32.56 Million SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q4 | 40.85 Million SEK | 0.0% |
| 2018 FY | 40.85 Million SEK | 36.11% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | -100.0% |
| 2017 FY | 30.01 Million SEK | 21.5% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q4 | 30.01 Million SEK | 0.0% |
| 2016 Q1 | - SEK | -100.0% |
| 2016 FY | 24.7 Million SEK | 81.72% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | 24.7 Million SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q1 | - SEK | -100.0% |
| 2015 Q4 | 13.59 Million SEK | 0.0% |
| 2015 FY | 13.59 Million SEK | -6.94% |
| 2014 Q4 | 14.61 Million SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 Q1 | - SEK | -100.0% |
| 2014 FY | 14.61 Million SEK | 25.05% |
| 2013 Q4 | 11.68 Million SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2013 FY | 11.68 Million SEK | -0.02% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 Q4 | 11.68 Million SEK | 0.0% |
| 2012 FY | 11.68 Million SEK | -20.66% |
| 2012 Q2 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q1 | - SEK | -100.0% |
| 2011 FY | 14.72 Million SEK | -74.25% |
| 2011 Q4 | 14.72 Million SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2010 Q4 | 57.18 Million SEK | 0.0% |
| 2010 FY | 57.18 Million SEK | -0.52% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2009 Q4 | 57.48 Million SEK | 0.0% |
| 2009 FY | 57.48 Million SEK | -32.21% |
| 2008 FY | 84.79 Million SEK | 41.19% |
| 2007 FY | 60.05 Million SEK | 26.3% |
| 2006 FY | 47.55 Million SEK | 6.26% |
| 2005 FY | 44.75 Million SEK | 30.61% |
| 2004 FY | 34.26 Million SEK | 244.34% |
| 2003 FY | 9.95 Million SEK | -15.1% |
| 2002 FY | 11.71 Million SEK | -28.51% |
| 2001 FY | 16.39 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -435.02% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 69.81% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 69.81% |
| Arcoma AB | 28.02 Million SEK | -30.553% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -23.423% |
| BICO Group AB (publ) | 493.1 Million SEK | 92.58% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 41.362% |
| CellaVision AB (publ) | 126.03 Million SEK | 70.969% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -498.365% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -1966.157% |
| C-Rad AB (publ) | 64.09 Million SEK | 42.917% |
| Duearity AB (publ) | 4.15 Million SEK | -779.779% |
| Dignitana AB (publ) | 7.41 Million SEK | -393.592% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -888.919% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.43% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 2273.615% |
| Iconovo AB (publ) | -4.86 Million SEK | 852.571% |
| Integrum AB (publ) | 22.36 Million SEK | -63.626% |
| Luxbright AB (publ) | 8000.00 SEK | -457275.0% |
| Mentice AB (publ) | 14.1 Million SEK | -159.43% |
| OssDsign AB (publ) | 4.3 Million SEK | -750.139% |
| Paxman AB (publ) | 19.99 Million SEK | -82.959% |
| Promimic AB (publ) | 330 Thousand SEK | -10987.879% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -401.783% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -206.989% |
| ScandiDos AB (publ) | 22.69 Million SEK | -61.26% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 14.857% |
| Senzime AB (publ) | 20.34 Million SEK | -79.892% |
| SpectraCure AB (publ) | 1.00 SEK | -3658999900.0% |
| Stille AB | 66.55 Million SEK | 45.021% |
| Vitrolife AB (publ) | 413 Million SEK | 91.14% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 74.16% |